我們已在上線! 進一步了解
SYNH

Syneos Health, Inc. Class A Common Stock

已下市

SYNH已於2023年9月27日下市。

 

關於: Syneos is a global contract research and outsourced commercialization organization that provides services to pharmaceutical and biotechnology firms. Its clinical solutions segment offers early- to late-stage clinical trial support that ranges from specialized staffing models to strategic partnerships that oversee nearly all aspects of a drug program, while the company's commercialization solutions includes outsourced sales, consulting, public relations, and advertising services.

員工: 29,395

新聞

正面
中性
負面
市場情緒 3個月
正面 0%
中性 0%
負面 0%

我們尚未收到任何關於SYNH的最新新聞文章。

價格圖表採用Lightweight Charts™實作